Abstract
[125I]Epidepride, (S)-(−)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo-2,3-dimethoxybenzamide ([125I]NCQ 219), is a new, extremly potent radioligand, useful in the study of the distribution of the dopamine D-2 receptors in the brain. Its synthesis requires radioiodination of the corresponding 5-(tributyltin) derivative. The aryltin precursor (TDP 526) can be conveniently prepared in high yield from isoremoxipride (FLB 457) by tetrakis(triphenylphosphine)palladium(0)-catalyzed stannylation using bis(tri-n-butyltin) in triethylamine. An improved method for the preparation of isoremoxipride from o-vanillin was developed.

This publication has 9 references indexed in Scilit: